Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × niraparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 6 Prostatic Neoplasms 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Disease Progression 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Nivolumab 19 cabozantinib 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Specimen Handling 12 Ipilimumab 12 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 avelumab 2 aldesleukin 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡